Skip to main content
SpringerLink
Log in

Capecitabine/lapatinib

Paronychia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hayashi M, et al. A case of trastuzumab-resistant breast cancer responding to lapatinib/capecitabine therapy. Gan to Kagaku Ryoho 41: 353-5, No. 3, Mar 2014 [Japanese; summarised from an English abstract] - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Capecitabine/lapatinib. Reactions Weekly 1506, 9 (2014). https://doi.org/10.1007/s40278-014-1444-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1444-y

Search

Navigation